Comparison of 18F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression-Reference-Cited by-同舟云学术

Comparison of 18F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression

Published:2013-05-02 Issue:6 Volume:15 Page:758-767
ISSN:1536-1632
Container-title:Molecular Imaging and Biology
language:en
Short-container-title:Mol Imaging Biol

Author:

Zhang Xiao-Xiang,Sun Zhongchan,Guo Jinxia,Wang Zhe,Wu Chenxi,Niu Gang,Ma Ying,Kiesewetter Dale O.,Chen Xiaoyuan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11307-013-0640-0.pdf

Reference41 articles.

1. Balkwill F (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14:171–179

2. Zhou Y, Larsen PH, Hao C, Yong VW (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277:49481–49487

3. Corcione A, Ottonello L, Tortolina G et al (2000) Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. J Natl Cancer Inst 92:628–635

4. Koshiba T, Hosotani R, Miyamoto Y et al (2000) Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6:3530–3535

5. Scotton CJ, Wilson JL, Scott K et al (2002) Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62:5930–5938

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review;Journal of Clinical Medicine;2024-05-16

2. Nanobiotechnology augmented cancer stem cell guided management of cancer: liquid-biopsy, imaging, and treatment;Journal of Nanobiotechnology;2024-04-12

3. Advances in peptide-based drug delivery systems;Heliyon;2024-02

4. Current Chemistry behind Peptide-based PET Probes 11C and 18F;Current Organic Chemistry;2023-08

5. Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling;RSC Medicinal Chemistry;2023